REGN Regeneron Pharmaceuticals, Inc.
15,582
$974.92
$2.04
(0.21%)
| Watchers | 15,582 |
| 52-Wk Low | $684.81 |
| 52-Wk High | $998.33 |
| Market Cap | $107.63B |
| Volume | 377.00 |
| 52-Wk High | $998.33 |
| 52-Wk Low | $684.81 |
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 YearsBenzinga • 12 days ago
read more...
Share to Feed
read more...
The Law Offices of Frank R. Cruz announces an investigation of Regeneron Pharmaceuticals, Inc. (Regeneron or the Company) (NASDAQ: REGN) on behalf of investors concerning the Companys possible...
:max_bytes(150000):strip_icc()/REGNChart-26db51c5b1184ddb8304e459b1875334.GIF)
Source: TradingView.com
Key TakeawaysRegeneron shares were lower ahead of the opening bell Thursday morning after the DOJ filed a complaint accusing the drugmaker of manipulating Medicare's drug...
:max_bytes(150000):strip_icc()/GettyImages-2010459008-079015b576724d41a3092e1cfb3678d6.jpg)
News of the day for April 11, 2024
Michael M. Santiago / Getty Images
U.S. stock futures are edging lower in premarket trading after tumbling Wednesday on the back of a hotter-than-forecast...
Regulatory applications for linvoseltamab currently under review by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)TARRYTOWN, N.Y., April 07, 2024 (GLOBE NEWSWIRE...
DekaBank Deutsche Girozentrale lifted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 11.9% in the fourth quarter, according to the company in its most recent...
Moody Lynn Lieberson LLC grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 1,592.9% during the fourth quarter, according to its most recent 13F...
Hartford Investment Management Co. decreased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 1.3% in the 4th quarter, Holdings Channel reports. The firm owned 7,219 shares...
Fifth Third Bancorp reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 0.7% during the fourth quarter, according to the company in its most recent disclosure with...